Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General transcription factor IIi pseudogene (GTF2I pseudogene)
- Target
- GTF2I pseudogene
- Molecular classification
- Pseudogene, Non-coding DNA
01
Overview
The general transcription factor IIi pseudogene (GTF2I pseudogene), referenced by Ensembl ID ENSG00000228327, is a non-functional DNA segment derived from the parental general transcription factor IIi gene. Pseudogenes resemble functional genes in sequence but carry disabling mutations, such as premature stop codons and frame-shifts, preventing expression of a functional protein. Although most pseudogenes were historically considered genomic "junk," some transcribed pseudogenes may have regulatory roles via RNA molecules—acting as small interfering RNAs or competing endogenous RNAs to modulate other gene expression. However, the GTF2I pseudogene itself has not been characterized as having any prominent biological function or disease relevance, and is not a therapeutic target, biomarker, or safety concern for drug development.
- Other names
- general transcription factor IIi (GTF2I) pseudogeneENSG00000228327 (Ensembl ID)
02
Mechanism of action
None applicable, as there are no drugs acting on this pseudogene
03
Biological functions
No known direct biological function; pseudogenes are typically non-functionalMay play a role in genomic regulation at the RNA level
04
Disease associations
No direct disease association, but some pseudogenes have been reported in aberrant expression profiles in cancer and other diseases
Beyond the preview
Go deeper on General transcription factor IIi pseudogene (GTF2I pseudogene).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on General transcription factor IIi pseudogene (GTF2I pseudogene).